TrialInternational journal of nanomedicine2014

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer.

Si Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.